-+ 0.00%
-+ 0.00%
-+ 0.00%

Scienture Q3 net loss widens 67% year over year to $6.01 million; Q3 revenue more than doubles year over year to $1.25 million

PUBT·11/19/2026 21:13:51
Diffusion vocale
Scienture Q3 net loss widens 67% year over year to $6.01 million; Q3 revenue more than doubles year over year to $1.25 million
  • Scienture Holdings’ third-quarter 2026 net loss widened 67% year-over-year to $6.01 million.
  • Revenue more than doubled year-over-year to $1.25 million, more than tripling from the second quarter.
  • REZENOPY’s August launch generated approximately $925,000 in initial wholesale revenue during the third quarter, primarily driving sequential growth.
  • Management expects profitability in 2027 through anticipated growth in product revenue.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scienture Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-053245), on November 19, 2026, and is solely responsible for the information contained therein.